An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells. / Papaccio, Gianpaolo; Nicoletti, Ferdinando; Pisanti, Francesco A; Galdieri, Michela; Bendtzen, Klaus.

In: Molecular Medicine, Vol. 8, No. 9, 01.09.2002, p. 536-45.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Papaccio, G, Nicoletti, F, Pisanti, FA, Galdieri, M & Bendtzen, K 2002, 'An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells', Molecular Medicine, vol. 8, no. 9, pp. 536-45.

APA

Papaccio, G., Nicoletti, F., Pisanti, F. A., Galdieri, M., & Bendtzen, K. (2002). An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells. Molecular Medicine, 8(9), 536-45.

Vancouver

Papaccio G, Nicoletti F, Pisanti FA, Galdieri M, Bendtzen K. An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells. Molecular Medicine. 2002 Sep 1;8(9):536-45.

Author

Papaccio, Gianpaolo ; Nicoletti, Ferdinando ; Pisanti, Francesco A ; Galdieri, Michela ; Bendtzen, Klaus. / An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells. In: Molecular Medicine. 2002 ; Vol. 8, No. 9. pp. 536-45.

Bibtex

@article{993cced49a0843849b8ed93cbc8e8285,
title = "An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells",
abstract = "In vitro studies have demonstrated that interleukin (IL)-1beta decreases insulin and DNA contents in pancreatic islet beta cells, causing structural damage, that it is toxic to cultured human islet beta cells and that it is able to induce apoptosis in these cells.",
author = "Gianpaolo Papaccio and Ferdinando Nicoletti and Pisanti, {Francesco A} and Michela Galdieri and Klaus Bendtzen",
year = "2002",
month = sep,
day = "1",
language = "English",
volume = "8",
pages = "536--45",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "BioMed Central",
number = "9",

}

RIS

TY - JOUR

T1 - An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells

AU - Papaccio, Gianpaolo

AU - Nicoletti, Ferdinando

AU - Pisanti, Francesco A

AU - Galdieri, Michela

AU - Bendtzen, Klaus

PY - 2002/9/1

Y1 - 2002/9/1

N2 - In vitro studies have demonstrated that interleukin (IL)-1beta decreases insulin and DNA contents in pancreatic islet beta cells, causing structural damage, that it is toxic to cultured human islet beta cells and that it is able to induce apoptosis in these cells.

AB - In vitro studies have demonstrated that interleukin (IL)-1beta decreases insulin and DNA contents in pancreatic islet beta cells, causing structural damage, that it is toxic to cultured human islet beta cells and that it is able to induce apoptosis in these cells.

M3 - Journal article

VL - 8

SP - 536

EP - 545

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 9

ER -

ID: 34101966